With extensive experience in venture capital, the fund manager has built a diverse portfolio across technology and healthcare sectors, primarily focusing on early-stage investments. Active in the U.S. and select international markets, they have successfully executed over 50 deals, showcasing a strong operator-first strategy. Noteworthy exits include several high-growth companies that have achieved significant market presence. Their analytical approach is underpinned by a data-driven methodology, ensuring strategic alignment with emerging trends and innovation.